Toxicogenomics and clinical toxicology: an example of the connection between basic and applied sciences

Area of Science:

• Toxicology
• Molecular Biology
• Genetics

Background:

• Clinical toxicology relies on experimental research, but inter-species variations complicate human effect prediction.
• Predicting clinical outcomes is challenging due to significant differences in toxicity expression.
• Existing methods struggle with inter- and intra-species variability in toxicological responses.

Purpose of the Study:

• To demonstrate how recent molecular biology research aids clinical toxicology.
• To illustrate the application of gene and protein studies in understanding chemical toxicity.
• To highlight the role of molecular targets in inter-individual susceptibility.

Main Methods:

• Utilizing new molecular biology techniques to study toxicokinetic and toxicodynamic processes.
• Investigating the role of specific genes and proteins in toxicological pathways.
• Analyzing variations in the expression and functionality of molecular targets.

Main Results:

• Molecular biology tools provide insights into toxicokinetic and toxicodynamic mechanisms.
• Research on genes and proteins clarifies inter-individual differences in chemical susceptibility.
• Examples show direct applications of molecular research to clinical toxicology challenges.

Conclusions:

• Advances in molecular biology significantly enhance clinical toxicology research.
• Understanding molecular targets is crucial for predicting individual responses to toxicants.
• Gene and protein research offers valuable tools for addressing clinical toxicology issues.